data13F

Esperion Therapeutics Inc

Held by 0 of 60 tracked investors in their latest 13F filing

Investors holding0
Combined shares0
Combined reported value$0

Ownership

Investor% of their portfolioChangeSharesReported valuePeriod
George Soros0.00Closed0–Q3 2026

Activity: last 4 quarters

PeriodInvestorChangeShares afterEffect on their portfolio (pts)
Q3 2026George Soros narrow view Closed00.04
Q2 2026George Soros narrow view New757,3580.04
Q1 2026Polen Capital Closed00.00
Q4 2025Polen Capital New116,2920.00

Added: opened or increased

PeriodInvestorChangeShares afterEffect on their portfolio (pts)
Q2 2026George Soros narrow view New757,3580.04
Q4 2025Polen Capital New116,2920.00

Reduced: reduced or closed

PeriodInvestorChangeShares afterEffect on their portfolio (pts)
Q3 2026George Soros narrow view Closed00.04
Q1 2026Polen Capital Closed00.00

History

2 peakQ2 2026: 1 tracked investors
Q3 2013: 1 tracked investorsQ1 2015: 2 tracked investorsQ3 2015: 1 tracked investorsQ3 2017: 1 tracked investorsQ4 2018: 1 tracked investorsQ1 2019: 1 tracked investorsQ2 2019: 1 tracked investorsQ3 2020: 1 tracked investorsQ4 2020: 1 tracked investorsQ1 2021: 1 tracked investorsQ2 2021: 1 tracked investorsQ3 2021: 1 tracked investorsQ4 2021: 1 tracked investorsQ1 2022: 1 tracked investorsQ2 2022: 1 tracked investorsQ3 2022: 1 tracked investorsQ4 2022: 1 tracked investorsQ1 2023: 1 tracked investorsQ2 2023: 1 tracked investorsQ3 2023: 1 tracked investorsQ1 2024: 1 tracked investorsQ4 2025: 1 tracked investorsQ2 2026: 1 tracked investors
20132026
Tracked investors reporting this stock, by quarter

Shares held, last 8 quarters

InvestorQ3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024
George Soros–757.4K––––––

– = not held that quarter. n/a = no holdings report for that quarter (not filed yet, or reported under another manager).